These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24457553)

  • 1. Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands.
    Bell R; Duke AA; Gilmore PE; Page D; Bègue L
    Sci Rep; 2014 Jan; 4():3881. PubMed ID: 24457553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety.
    Nic Dhonnchadha BA; Bourin M; Hascoët M
    Behav Brain Res; 2003 Mar; 140(1-2):203-14. PubMed ID: 12644293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.
    de Mello Cruz AP; Pinheiro G; Alves SH; Ferreira G; Mendes M; Faria L; Macedo CE; Motta V; Landeira-Fernandez J
    Psychopharmacology (Berl); 2005 Nov; 182(3):345-54. PubMed ID: 16133141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
    Griebel G; Perrault G; Sanger DJ
    Neuropharmacology; 1997 Jun; 36(6):793-802. PubMed ID: 9225307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice.
    Bourin M; Hascoët M
    Behav Brain Res; 2010 Apr; 208(2):352-8. PubMed ID: 20006646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze.
    Zhang ZJ; Schmidt DE; de Paulis T; Trivedi BL; Onaivi ES; Ebert MH; Hewlett WA
    Pharmacol Biochem Behav; 2001; 69(3-4):571-8. PubMed ID: 11509218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 5-HT
    Charousaei A; Nasehi M; Babapour V; Vaseghi S; Zarrindast MR
    Behav Brain Res; 2021 Jan; 397():112933. PubMed ID: 32991927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice.
    Cao BJ; Rodgers RJ
    Psychopharmacology (Berl); 1998 Oct; 139(3):185-94. PubMed ID: 9784072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-HT4 receptor antagonists on rat behaviour in the elevated plus-maze test.
    Silvestre JS; Fernández AG; Palacios JM
    Eur J Pharmacol; 1996 Aug; 309(3):219-22. PubMed ID: 8874143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression.
    Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Behav Pharmacol; 2004 Dec; 15(8):523-34. PubMed ID: 15577451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice.
    Nic Dhonnchadha BA; Hascoët M; Jolliet P; Bourin M
    Behav Brain Res; 2003 Dec; 147(1-2):175-84. PubMed ID: 14659583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation.
    Fontana DJ; Daniels SE; Wong EH; Clark RD; Eglen RM
    Neuropharmacology; 1997; 36(4-5):689-96. PubMed ID: 9225295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze.
    Setem J; Pinheiro AP; Motta VA; Morato S; Cruz AP
    Pharmacol Biochem Behav; 1999 Mar; 62(3):515-21. PubMed ID: 10080245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism.
    Eguchi J; Inomata Y; Saito K
    Pharmacol Biochem Behav; 2001 Apr; 68(4):677-83. PubMed ID: 11526964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
    Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Neuropharmacology; 2000 Jul; 39(10):1848-57. PubMed ID: 10884565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT4 receptors improve social olfactory memory in the rat.
    Letty S; Child R; Dumuis A; Pantaloni A; Bockaert J; Rondouin G
    Neuropharmacology; 1997; 36(4-5):681-7. PubMed ID: 9225294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice.
    Chegini HR; Nasehi M; Zarrindast MR
    Behav Brain Res; 2014 Mar; 261():114-26. PubMed ID: 24333573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
    Vicente MA; Zangrossi H
    Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.